|
|
Volumn 45, Issue 3, 2014, Pages 363-371
|
|
In the war against solid tumors arsenic trioxide needs partners
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
GLI1 PROTEIN, HUMAN;
ONCOPROTEIN;
ORGANOARSENIC DERIVATIVE;
OXIDE;
PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN;
SONIC HEDGEHOG PROTEIN;
THYMIDYLATE SYNTHASE;
TRANSCRIPTION FACTOR;
TUMOR PROTEIN;
ADJUVANT THERAPY;
ANTAGONISTS AND INHIBITORS;
APOPTOSIS;
BRAIN DISEASE;
CHEMICALLY INDUCED;
CHINESE MEDICINE;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG EFFECTS;
DRUG POTENTIATION;
FOOD AND DRUG ADMINISTRATION;
HEMATOLOGIC DISEASE;
HUMAN;
MULTIMODALITY CANCER THERAPY;
NEOPLASMS;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
ARSENICALS;
BRAIN DISEASES;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
DRUG APPROVAL;
DRUG SYNERGISM;
HEDGEHOG PROTEINS;
HEMATOLOGIC DISEASES;
HUMANS;
MEDICINE, CHINESE TRADITIONAL;
NEOPLASM PROTEINS;
NEOPLASMS;
ONCOGENE PROTEINS, FUSION;
OXIDES;
RADIOTHERAPY, ADJUVANT;
SIGNAL TRANSDUCTION;
THYMIDYLATE SYNTHASE;
TRANSCRIPTION FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 85027923556
PISSN: None
EISSN: 19416636
Source Type: Journal
DOI: 10.1007/s12029-014-9617-8 Document Type: Review |
|
Times cited : (50)
|
|
References (0)
|